Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY RADIOISOTOPE
4.1. Overview
4.1.1. Market Size and Forecast, By Radioisotope
4.2. Technetium 99m
4.3. Fluorine 18
4.4. Iodine I
4.5. Gallium 68
4.6. Others
Chapter 5: SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Cancer
5.3. Cardiology
5.4. Others
Chapter 6: SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY TYPE
6.1. Overview
6.1.1. Market Size and Forecast, By Type
6.2. Diagnostic
6.3. Therapeutic
Chapter 7: SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY END USER
7.1. Overview
7.1.1. Market Size and Forecast, By End User
7.2. Hospitals and clinics
7.3. Medical Imaging centers
7.4. Others
Chapter 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
Chapter 9: COMPANY PROFILES
9.1. Jubilant Life Sciences
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Gulf Pharmaceutical Industries (Julphar)
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Al-Azizia Panda United Company
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. National Oil Company (NOC)
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Saudi Chemical Company (SCC)
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Saudi Organics Industries
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Saudi International Chemicals LTD (SICL)
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Saudi Arabian Petrochemical Company (Ibn Zahr)
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Al Fanar Pharmacy Company
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments



List of Figures

FIGURE 01. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN SAUDI ARABIA RADIOPHARMACEUTICALS MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: SAUDI ARABIA RADIOPHARMACEUTICALS MARKET
FIGURE 10. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET,BY RADIOISOTOPE, 2022 ($MILLION)
FIGURE 11. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET,BY TYPE, 2022 ($MILLION)
FIGURE 13. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET,BY END USER, 2022 ($MILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: SAUDI ARABIA RADIOPHARMACEUTICALS MARKET
FIGURE 20. TOP PLAYER POSITIONING, 2022
FIGURE 21. JUBILANT LIFE SCIENCES: NET SALES, 2020-2022*?($MILLION)
FIGURE 22. JUBILANT LIFE SCIENCES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 23. JUBILANT LIFE SCIENCES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 24. SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO): NET SALES, 2020-2022*?($MILLION)
FIGURE 25. SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 26. SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 27. GULF PHARMACEUTICAL INDUSTRIES (JULPHAR): NET SALES, 2020-2022*?($MILLION)
FIGURE 28. GULF PHARMACEUTICAL INDUSTRIES (JULPHAR): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 29. GULF PHARMACEUTICAL INDUSTRIES (JULPHAR): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 30. AL-AZIZIA PANDA UNITED COMPANY: NET SALES, 2020-2022*?($MILLION)
FIGURE 31. AL-AZIZIA PANDA UNITED COMPANY: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 32. AL-AZIZIA PANDA UNITED COMPANY: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 33. NATIONAL OIL COMPANY (NOC): NET SALES, 2020-2022*?($MILLION)
FIGURE 34. NATIONAL OIL COMPANY (NOC): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 35. NATIONAL OIL COMPANY (NOC): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 36. SAUDI CHEMICAL COMPANY (SCC): NET SALES, 2020-2022*?($MILLION)
FIGURE 37. SAUDI CHEMICAL COMPANY (SCC): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 38. SAUDI CHEMICAL COMPANY (SCC): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 39. SAUDI ORGANICS INDUSTRIES: NET SALES, 2020-2022*?($MILLION)
FIGURE 40. SAUDI ORGANICS INDUSTRIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 41. SAUDI ORGANICS INDUSTRIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 42. SAUDI INTERNATIONAL CHEMICALS LTD (SICL): NET SALES, 2020-2022*?($MILLION)
FIGURE 43. SAUDI INTERNATIONAL CHEMICALS LTD (SICL): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 44. SAUDI INTERNATIONAL CHEMICALS LTD (SICL): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 45. SAUDI ARABIAN PETROCHEMICAL COMPANY (IBN ZAHR): NET SALES, 2020-2022*?($MILLION)
FIGURE 46. SAUDI ARABIAN PETROCHEMICAL COMPANY (IBN ZAHR): REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 47. SAUDI ARABIAN PETROCHEMICAL COMPANY (IBN ZAHR): REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 48. AL FANAR PHARMACY COMPANY: NET SALES, 2020-2022*?($MILLION)
FIGURE 49. AL FANAR PHARMACY COMPANY: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 50. AL FANAR PHARMACY COMPANY: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

TABLE 01. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY RADIOISOTOPE, 2022-2032 ($MILLION)
TABLE 02. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 04. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 05. JUBILANT LIFE SCIENCES: KEY EXECUTIVES
TABLE 06. JUBILANT LIFE SCIENCES: COMPANY SNAPSHOT
TABLE 07. JUBILANT LIFE SCIENCES: OPERATING SEGMENTS
TABLE 08. JUBILANT LIFE SCIENCES: PRODUCT PORTFOLIO
TABLE 09. JUBILANT LIFE SCIENCES: KEY STRATERGIES
TABLE 10. SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO): KEY EXECUTIVES
TABLE 11. SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO): COMPANY SNAPSHOT
TABLE 12. SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO): OPERATING SEGMENTS
TABLE 13. SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO): PRODUCT PORTFOLIO
TABLE 14. SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO): KEY STRATERGIES
TABLE 15. GULF PHARMACEUTICAL INDUSTRIES (JULPHAR): KEY EXECUTIVES
TABLE 16. GULF PHARMACEUTICAL INDUSTRIES (JULPHAR): COMPANY SNAPSHOT
TABLE 17. GULF PHARMACEUTICAL INDUSTRIES (JULPHAR): OPERATING SEGMENTS
TABLE 18. GULF PHARMACEUTICAL INDUSTRIES (JULPHAR): PRODUCT PORTFOLIO
TABLE 19. GULF PHARMACEUTICAL INDUSTRIES (JULPHAR): KEY STRATERGIES
TABLE 20. AL-AZIZIA PANDA UNITED COMPANY: KEY EXECUTIVES
TABLE 21. AL-AZIZIA PANDA UNITED COMPANY: COMPANY SNAPSHOT
TABLE 22. AL-AZIZIA PANDA UNITED COMPANY: OPERATING SEGMENTS
TABLE 23. AL-AZIZIA PANDA UNITED COMPANY: PRODUCT PORTFOLIO
TABLE 24. AL-AZIZIA PANDA UNITED COMPANY: KEY STRATERGIES
TABLE 25. NATIONAL OIL COMPANY (NOC): KEY EXECUTIVES
TABLE 26. NATIONAL OIL COMPANY (NOC): COMPANY SNAPSHOT
TABLE 27. NATIONAL OIL COMPANY (NOC): OPERATING SEGMENTS
TABLE 28. NATIONAL OIL COMPANY (NOC): PRODUCT PORTFOLIO
TABLE 29. NATIONAL OIL COMPANY (NOC): KEY STRATERGIES
TABLE 30. SAUDI CHEMICAL COMPANY (SCC): KEY EXECUTIVES
TABLE 31. SAUDI CHEMICAL COMPANY (SCC): COMPANY SNAPSHOT
TABLE 32. SAUDI CHEMICAL COMPANY (SCC): OPERATING SEGMENTS
TABLE 33. SAUDI CHEMICAL COMPANY (SCC): PRODUCT PORTFOLIO
TABLE 34. SAUDI CHEMICAL COMPANY (SCC): KEY STRATERGIES
TABLE 35. SAUDI ORGANICS INDUSTRIES: KEY EXECUTIVES
TABLE 36. SAUDI ORGANICS INDUSTRIES: COMPANY SNAPSHOT
TABLE 37. SAUDI ORGANICS INDUSTRIES: OPERATING SEGMENTS
TABLE 38. SAUDI ORGANICS INDUSTRIES: PRODUCT PORTFOLIO
TABLE 39. SAUDI ORGANICS INDUSTRIES: KEY STRATERGIES
TABLE 40. SAUDI INTERNATIONAL CHEMICALS LTD (SICL): KEY EXECUTIVES
TABLE 41. SAUDI INTERNATIONAL CHEMICALS LTD (SICL): COMPANY SNAPSHOT
TABLE 42. SAUDI INTERNATIONAL CHEMICALS LTD (SICL): OPERATING SEGMENTS
TABLE 43. SAUDI INTERNATIONAL CHEMICALS LTD (SICL): PRODUCT PORTFOLIO
TABLE 44. SAUDI INTERNATIONAL CHEMICALS LTD (SICL): KEY STRATERGIES
TABLE 45. SAUDI ARABIAN PETROCHEMICAL COMPANY (IBN ZAHR): KEY EXECUTIVES
TABLE 46. SAUDI ARABIAN PETROCHEMICAL COMPANY (IBN ZAHR): COMPANY SNAPSHOT
TABLE 47. SAUDI ARABIAN PETROCHEMICAL COMPANY (IBN ZAHR): OPERATING SEGMENTS
TABLE 48. SAUDI ARABIAN PETROCHEMICAL COMPANY (IBN ZAHR): PRODUCT PORTFOLIO
TABLE 49. SAUDI ARABIAN PETROCHEMICAL COMPANY (IBN ZAHR): KEY STRATERGIES
TABLE 50. AL FANAR PHARMACY COMPANY: KEY EXECUTIVES
TABLE 51. AL FANAR PHARMACY COMPANY: COMPANY SNAPSHOT
TABLE 52. AL FANAR PHARMACY COMPANY: OPERATING SEGMENTS
TABLE 53. AL FANAR PHARMACY COMPANY: PRODUCT PORTFOLIO
TABLE 54. AL FANAR PHARMACY COMPANY: KEY STRATERGIES